NVDA closed at $216.00 on October 26, 2026, up $5.04 or 2.39% from $210.96 on 90.0 million shares — 0.88x the 20-day average of 102.7 million and 0.86x the 60-day average of 104.3 million — after trading a $5.14 range between $212.61 and $217.75, equal to 2.38% of price, and closing near the session high. The bounce reverses part of the 11.82% October drawdown and leaves price 11.25% below the $243.37 52-week high, 31.49% above the $164.27 low and at the 65.4 percentile of the annual range, with the stock +1.81% year-to-date and -4.03% over the trailing month. Trend structure is still repairing: price is 5.07% above the rising 200-day at $205.58 but 2.10% below the 50-day at $220.63 and 3.96% below the 20-day at $224.90, while the / golden-cross spread remains intact at 7.32%. Momentum improved from a deeply oversold condition — rose to 44.14 from 38.11, the histogram narrowed to -1.789 from -2.159, and jumped 18.84% to 567.9 million — though remains 53.3% below the October 6 peak of 1.216 billion and the line is still negative at -2.707. The macro backdrop is less hostile: fell 5.45% to 18.39, the 10-year yield is 4.986%, and the S&P 500 (+0.70%), Nasdaq (+0.82%) and Dow (+0.28%) all advanced. Fundamentals remain exceptional — 105.9% revenue growth, 127.8% earnings growth, 74.67% gross margin, 66.24% operating margin, $134.36 billion operating cash flow, $41.81 billion free cash flow and $23.61 billion net cash — and all six supplied quarters beat consensus by an average of 5.43%. Valuation has compressed to 27.31x trailing, 13.57x the $15.9146 out-year estimate and a 0.258 , but it still costs 17.22x sales and 25.14x with a 0.8% FCF yield against a 4.986% risk-free rate. The revision picture is bifurcated: the +1-year estimate is up 24.19% in 90 days with seven upward and zero downward 30-day revisions, while current- and next-quarter estimates each carry one downward and zero upward revisions. No company-specific news has entered the bundle since September 30, so the recent move has been positioning-driven; the November 17 report is now 21 days away and is the dominant event. Net: HOLD for one month because the bounce is one session old, volume is below average and a binary print sits inside the window, but retain BUY at six months, one year and overall because the franchise, balance sheet and out-year revision trend remain intact at a de-rated multiple.
Decision
Live price
$217.79
Recommendation score
72%
72%
Confidence
68%
68%
Outlook by horizon
1M
HOLD
Near
6M
BUY
Mid
1Y
BUY
Long
Primary catalyst
The November 17 earnings report is the highest-impact item because it is 21 days away and will test whether the $15.9146 out-year estimate — already raised 24.19% in 90 days — can be defended while current- and next-quarter estimates each carry one downward and zero upward revisions over the past 30 days. The secondary structural item is the DeepSeek-Huawei open-source Ascend toolchain, which targets the developer-ecosystem lock-in supporting NVIDIA's 66.24% operating margin, though Huawei's broader training ambitions are not targeted until 2027 and no share loss is quantified.
Stability ClassHigh-Beta GrowthPortfolio RoleCore GrowthDrawdown RiskHighRisk ProfileAggressiveSemiconductorsAI Infrastructure200-Day EMA SupportBelow 50-Day EMAPositive Out-Year RevisionsRate-Sensitive ValuationChina AI Stack RiskEarnings Nov 17 (21 days)
Decision Workspace
Price Map
60-day setup
Price rail
$217.79
Stop
Now
$193
$211
$229
$248
Stop loss
$197.50
Entry
$205.50 - $214.00
Exit
$221.00 - $243.00
Risk / reward
1.8x
Watch size
Downside to stop
-9.3%
Upside to exit
+11.6%
Position sizing
Hold roughly 45-55% of normal single-name risk, modestly above the prior run's 40-50% band because October 26 delivered a 2.39% reversal on a close near the session high, with recovering to 44.14, the histogram narrowing to -1.789 and up 18.84%. The trend is still not repaired — price is 2.10% below the and 3.96% below the , the line is -2.707, and earnings are 21 days away — so do not add at market. Reserve the remaining capital for either a volume-confirmed reclaim of $220.63 or a successful retest of the rising 200-day at $205.58; treat any size carried into November 17 as a separately budgeted event position.
Thesis Snapshot
Why It Works
The strongest case for owning NVDA here is that the October 26 session produced the first credible technical repair in two weeks while the fundamental engine remains intact and the valuation has de-rated. The stock rose 2.39% to $216.00, closed near its $217.75 high, recovered 5.07% above the rising 200-day at $205.58 and outperformed the Nasdaq's +0.82% gain. rebounded to 44.14 from 38.11, the histogram narrowed to -1.789 from -2.159, and jumped 18.84% to 567.9 million. The business still grew revenue 105.9% and earnings 127.8% year over year, gross margin is 74.67%, operating margin is 66.24%, operating cash flow is $134.36 billion, free cash flow is $41.81 billion and the company holds $23.61 billion of net cash. All six supplied quarters beat consensus by an average of 5.43%, the +1-year estimate has climbed 24.19% in 90 days to $15.9146 with zero downward 30-day revisions and three upward revisions in the last week, and the forward has compressed to 13.57x with a 0.258 . The $328.95 mean target implies 52.3% upside, the / golden-cross structure remains intact at a 7.32% spread, and the prior $202-$211 entry band was tested on October 23 (low $210.18, close $210.96) before the stock moved above it to $216.00; the $197.50 stop remains untriggered and the $221-$243 exit reference was not reached (October 26 high $217.75). The plan has not failed, it has moved from anticipation to execution, which is why the position size band was nudged up rather than cut.
What Breaks It
The strongest argument against owning NVDA right now is that one 2.39% bounce on below-average volume does not undo a thirteen-session distribution in which the stock fell 11.82% with essentially no company-specific news. October 26 volume of 90.0 million was only 0.88x the 20-day average and 0.86x the 60-day average, so buyers have not yet demonstrated institutional commitment. Price remains 2.10% below the 50-day at $220.63 and 3.96% below the 20-day at $224.90, the line is still -2.707 with the signal at -0.918, and is 53.3% below its October 6 peak even after the 18.84% bounce. The valuation offers no cushion: 17.22x sales, 25.14x , 22.78x book and a 0.8% free-cash-flow yield against a 4.986% risk-free rate, a negative spread of roughly 419 basis points. The 13.57x forward that anchors the bull case rests entirely on a $15.9146 out-year estimate 70.9% above the current-year $9.31242, so the 'cheap' label is a 2027 bet whose support disappears the moment revisions stall — and near-term revisions have already flattened with one downward and zero upward changes in both the current and next quarter. The short thesis is straightforward: hyperscaler capex growth decelerates into calendar 2027, Chinese software substitution erodes developer lock-in, and a 5% risk-free rate caps the multiple, producing the de-rating that has already begun. Critically, short interest is only 1.34% of float with a 2.75 short ratio and no time series supplied, so there is no evidence bearish positioning is building and therefore no short base to fuel a squeeze — the unwind can grind lower without a violent reversal. Finally, insider data is unusable this run, removing one independent confirmation exactly when it would be most valuable ahead of a binary November 17 print.
A decisive close below the rising 200-day at $205.58 — particularly a close under $197.50 on above-average volume — would confirm that the long-term uptrend structure has failed and require exiting the position regardless of the fundamental story. The secondary fundamental invalidation would be a November 17 guide-down or a data-center revenue deceleration that forces the $15.9146 out-year estimate to be revised lower, since that estimate is the sole support under the 13.57x forward multiple.
Incomplete technical repair: price closed at $216.00 on October 26, still 2.10% below the 50-day ($220.63) and 3.96% below the 20-day ($224.90); the line is -2.707 with the histogram at -1.789, is 44.14 with no confirmed bullish divergence, and remains 53.3% below its October 6 peak of 1.216 billion.
Earnings event risk inside the window: the November 17 report is 21 days out, the +1-year estimate has already risen 24.19% in 90 days while current- and next-quarter estimates each show one downward and zero upward revisions over the past 30 days, and a 2.83% plus 29.29% realized volatility and 2.216 beta imply a 7-12% gap on any guide-down — enough to gap straight through the $197.50 stop.
Valuation and rate sensitivity: 17.22x sales, 25.14x , 22.78x book and a 0.8% FCF yield against a 4.986% 10-year yield mean the 13.57x forward depends on an out-year estimate 70.9% above the current-year figure; a push through 5% on the 10-year would remove support underneath the multiple.
No company catalyst until November 17: the bundle contains no company-specific news after September 30, yet the stock fell 11.82% from the October 6 close before the October 26 bounce, meaning rotation and de-risking — not news — are driving the tape, and nothing in the calendar can reliably sustain the rebound for 21 days.
Relative-strength risk: October 26 was a positive session (+2.39% versus Nasdaq +0.82%), but the stock is still 4.03% lower over the trailing month and 11.25% below its 52-week high, so one day of outperformance has not reversed the broader de-rating of crowded AI mega-caps.
Volatility regime risk: fell 5.45% to 18.39, but it remains in the neutral band, 20-day realized volatility is 29.29%, and a move back above 20-22 on the would likely force further de-risking in exactly this high-multiple cohort.
Competitive and moat risk: DeepSeek and Huawei are building and open-sourcing an Ascend programming backbone plus a 128-chip Ascend 950 supernode, with Huawei targeting broad AI-chip use in training by 2027; no adoption or revenue-loss figure is quantified, so the magnitude is unknown even though China has largely blocked domestic NVIDIA sales.
Execution and capital-intensity risk: the roughly $92.55 billion gap between operating cash flow ($134.36 billion) and free cash flow ($41.81 billion) means system delivery, supply-chain or working-capital friction could defer revenue; the bundle contains no backlog, customer-concentration or segment revenue data to size this.
Analyst-target dispersion as a disagreement proxy: the low target of $180 sits 16.7% below the current price while the high of $515 stands 138.4% above it — a $335 spread equal to 155.1% of the share price — and with number_of_analysts null, the 10/49/2/1/0 tally cannot be validated as a distinct-analyst count, so consensus conviction may be overstated.
Insider-signal blind spot: the three supplied Form-4 rows have blank transaction types and null dollar values, so management's own buying or selling behavior cannot be assessed this run, removing one of the few independent confirmations available heading into an event-heavy quarter.
Watch Next
Next earnings: Nov 17, 2026
The November 17 earnings report is the highest-impact item because it is 21 days away and will test whether the $15.9146 out-year estimate — already raised 24.19% in 90 days — can be defended while current- and next-quarter estimates each carry one downward and zero upward revisions over the past 30 days. The secondary structural item is the DeepSeek-Huawei open-source Ascend toolchain, which targets the developer-ecosystem lock-in supporting NVIDIA's 66.24% operating margin, though Huawei's broader training ambitions are not targeted until 2027 and no share loss is quantified.
Signal Dashboard
Decision inputs
6 signals
Fundamental
52.3%
Upside to analyst mean target
At the $216.00 close NVDA trades at 27.31x trailing earnings, 13.57x the $15.9146 out-year estimate and 22.78x book, with a supplied of 0.258 — optically cheap on forward earnings relative to growth, but the forward multiple rests entirely on an out-year estimate 70.9% above the current-year $9.31242. Absolute valuation remains demanding: 17.22x sales, 25.14x and a 0.8% free-cash-flow yield against a 4.986% ten-year Treasury yield, a negative spread of roughly 419 basis points. The supplied enterprise value of $5.0605 trillion is 0.97x the $5.2158 trillion market cap, consistent with the $23.61 billion net-cash position, which is only 0.45% of market cap and therefore a stability feature rather than a valuation floor. Price sits at the 65.4 percentile of its 52-week range, 11.25% below the $243.37 high and 31.49% above the $164.27 low, while the stock is down 4.03% over the trailing month but up 1.81% year-to-date despite 105.9% revenue growth and 127.8% earnings growth. The bundle supplies no peer or historical multiple series, so a precise ranking against AMD, Broadcom or Micron is not supportable. On available evidence NVDA is attractive on forward earnings relative to growth and expensive on sales, book and free cash flow — a profile that requires continued estimate escalation to defend the price.
Technical
Bearish
Trend quality
The October 26 close of $216.00 was a $5.04 (+2.39%) advance from $210.96 and a clear rejection of the October 23 marginal low at $210.18. Price is now 5.07% above the rising 200-day at $205.58, 2.10% below the 50-day at $220.63 and 3.96% below the 20-day at $224.90. The remains 7.32% above the , so the long-term golden-cross structure is intact rather than broken, but the intermediate trend is still down: the stock remains 11.25% below the $243.37 52-week high and has not yet reclaimed the 50-day after failing that level on October 22. This is a long-term uptrend with a maturing intermediate correction, not a structural trend failure — the 200-day held on a closing basis and is now the line that separates repair from breakdown.
Earnings
21d
Improving
For the quarter ended July 31, 2026, of $2.22 beat the $2.09113 estimate by 6.16%, the sixth consecutive beat in the supplied history and the largest absolute beat; sequential has risen from $0.81 to $2.22 across six quarters, although the percentage growth rate has moderated from roughly 29.6% to 18.7% and near-term quarterly estimates have flattened (current quarter -0.01% and next quarter +0.12% over 30 days, each with one downward and zero upward revisions), which is why the trend is labelled Improving rather than Accelerating; the post-report price reaction is not provided and the two older quarters needed to validate a full eight-quarter pattern are unavailable, so the 100% beat rate should be treated as directional rather than complete.
News
Mixed-Bearish
Headline tone
The November 17 earnings report is the highest-impact item because it is 21 days away and will test whether the $15.9146 out-year estimate — already raised 24.19% in 90 days — can be defended while current- and next-quarter estimates each carry one downward and zero upward revisions over the past 30 days. The secondary structural item is the DeepSeek-Huawei open-source Ascend toolchain, which targets the developer-ecosystem lock-in supporting NVIDIA's 66.24% operating margin, though Huawei's broader training ambitions are not targeted until 2027 and no share loss is quantified.
Macro
Neutral
4.99% 10Y / 18.4 VIX
at 18.39 is inside the 15-20 neutral band and fell 5.45%, but the 10-year yield at 4.986% still penalizes a 2.216-beta, 17.22x-sales name carrying only a 0.8% free-cash-flow yield.
Stability
High-Beta Growth
Core Growth
NVIDIA remains an elite business inside a violently volatile equity: 74.67% gross margin, 66.24% operating margin, 53.57% , $134.36 billion of operating cash flow, $41.81 billion of free cash flow and $23.61 billion of net cash. But the stock carries a 2.216 beta, 29.29% 20-day realized volatility, a $6.11 equal to 2.83% of price, and trades at 17.22x sales and 25.14x with a 0.8% free-cash-flow yield against a 4.986% ten-year yield. That combination belongs in a growth sleeve as a Core Growth holding sized so a 20-30% drawdown is survivable, not as a defensive anchor. Thesis durability remains High because revision breadth and the platform position are intact, but the October 26 bounce is only one session old and the November 17 earnings print is 21 days away.
Analyst Spread
Mean Target
$328.95
High / Low
$180 / $515
Median Target
$315.00
Consensus range
$180 - $515
— analysts
Mean
$180$329$515
Consensus
The mean target of $328.95 implies roughly 52.3% upside from $216.00 and the $315 median implies about 45.8%. The $180 low target sits 16.7% below the current price while the $515 high stands 138.4% above it — a $335 spread equal to 155.1% of the current share price and the clearest quantitative evidence of genuine disagreement on AI capex durability, China exposure and the appropriate multiple. The recommendation tally (10 Strong Buy, 49 Buy, 2 Hold, 1 Sell, 0 Strong Sell) is overwhelmingly constructive and static across the 0m, -1m, -2m and -3m snapshots, but number_of_analysts is null, so those entries should not be treated as a confirmed count of distinct analysts. Direction of travel matters more than the level: targets were maintained or initiated to the upside while the stock de-rated 11.25% from its high, which mechanically widens implied upside without any new analyst conviction.
Positioning Pulse
Insider Signal
Neutral
Net Bias
No recent activity
Insider Own.
4.0%
Institutional Own.
71.4%
Interpretation
The insider dataset is effectively unusable for signal generation this run — with no transaction types or dollar values there is no evidence of discretionary buying or selling, so the only defensible read is neutral and low-confidence, and one of the few independent confirmations available heading into a November 17 print is simply absent.
Notable activity
The extract contains three rows — Chief Financial Officer Colette M. Kress (139,640 direct shares), General Counsel Timothy S. Teter (122,220 direct shares) and Officer Debora C. Shoquist (57,489 direct shares) — but all three have blank transaction types, null dollar values and opaque date strings ('149', '148', '147'). Because direction, execution price and 10b5-1 versus open-market status are all missing, none of the rows can be classified as a purchase or a sale, and the disclosed share counts are too small relative to a $5.216 trillion market cap to be material even if the direction were known.
Market Context
Industry
Semiconductors
Mixed-Bullish
Sentiment
31
Tracked names
13
Grouping
industry
Semiconductors industry is currently Mixed-Bullish with an average recommendation score near 55. capital and conviction are improving across the group, and leadership is concentrated in TSM, AVGO, MU.
Rotation Drivers
Average recommendation deltas are trending higher across Semiconductors industry, which suggests improving risk appetite inside the group.
3 names are rated bullish versus 0 bearish names, keeping the group tone mixed-bullish.
Leadership is concentrated in TSM, AVGO, MU, so those names are the cleanest read on group-level capital rotation.
AI infrastructure remains the central demand narrative and the fundamental evidence is intact: 105.9% revenue growth, a 24.19% rise in the 90-day out-year estimate to $15.9146 with seven upward and zero downward 30-day revisions, and article-reported hedge-fund holders rising from 275 to 285 with aggregate holdings from roughly $83.9 billion to $94.7 billion. The leadership premium is still being repriced at the index level, but October 26 was a relative-strength session — NVDA rose 2.39% while the Nasdaq gained 0.82% — and the stock remains 11.25% below its 52-week high and only 1.81% higher year-to-date despite triple-digit growth. The theme is strengthening fundamentally while its equity expression remains volatile, which is the signature of position rotation rather than a demand break.
The out-year revision breadth and the September 28 Open Agent Safety Platform are colliding with a 21-day countdown to the November 17 print while the 10-year yield holds near 4.986% and sits at 18.39.
The +1-year estimate rose from $12.81483 to $15.9146 over 90 days (+24.19%), with seven upward and zero downward revisions in the past 30 days and three upward revisions in the last seven days.
The supplied article reports Q2 2026 hedge-fund holders rising from 275 to 285 and aggregate holdings from roughly $83.9 billion to $94.7 billion — lagged positioning, not real-time flow.
NVDA outperformed on October 26 (+2.39% versus Nasdaq +0.82%) while rose 18.84%, the first accumulation print since the October 6 peak.
Negative rotation evidence remains: is still 53.3% below its October 6 peak, 20-day realized volatility is 29.29% against a 2.216 beta, and average 20-day dollar volume of $23.11 billion shows the exit was orderly but persistent.
China Domestic AI Stack / De-Nvidia-ization
Score: -50
Bearish
The DeepSeek-Huawei partnership extends China's substitution push from hardware supply into software and programming tools — precisely the layer that creates NVIDIA's migration friction. DeepSeek is open-sourcing a programming backbone for Huawei's Ascend line, a 128-chip Ascend 950 supernode program has been advanced, and DeepSeek's V4-Flash model is reported optimized for Huawei silicon, with Huawei saying it expects broad AI-chip use in model training by 2027. Broader Huawei training ambitions are not targeted until 2027, the bundle quantifies no adoption or revenue loss, and China has already largely blocked domestic NVIDIA sales — so this is a credible strategic threat rather than a demonstrated near-term share loss, and no listed-equity flow or beneficiary pricing is provided to size it.
The September 30 announcement adds an open-source software toolchain to China's domestic AI chip effort, broadening the challenge beyond hardware-only substitution, and it remains the most recent substantive company-relevant item in a 26-day news vacuum during which NVDA fell 11.82% before the October 26 bounce.
DeepSeek and Huawei are developing and open-sourcing a programming backbone for the Ascend chip line, including a 128-chip Ascend 950 supernode program.
DeepSeek's V4-Flash model is reported optimized for Huawei silicon, and Huawei has said it expects broad AI-chip use in model training by 2027.
Chinese policy support for domestic AI chips and the article's statement that China has largely blocked domestic sales of NVIDIA chips formalize the substitution path, but the bundle contains no listed-equity flow or share-price evidence to quantify it.
Key Stats
23 metrics total
Market Cap
$5.22T
P/E (TTM)
27.3
Forward P/E
13.6
Revenue Growth
105.9%
ROE
117.2%
Beta
2.22
Full Metric Set
17 additional stats
Valuation Stack
Multiples and cash-flow framing.
Price / Sales
17.2
Price / Book
22.8
EV / EBITDA
25.1
Quality & Balance Sheet
Margins, leverage, and liquidity.
Gross Margin
74.7%
Operating Margin
66.2%
Debt / Equity
17.0
Current Ratio
4.59x
Quick Ratio
2.92x
Positioning & Range
Short interest and 52-week location.
Short % Float
1.3%
Short Ratio
2.75x
52W High
$243.37
52W Low
$164.27
From 52W High
-11.3%
From 52W Low
31.5%
Company Classification
Sector and industry context.
Sector
Technology
Industry
Semiconductors
Additional Signals
Free Cash Flow
$41809874944.00
Detailed Analysis
Valuation
At the $216.00 close NVDA trades at 27.31x trailing earnings, 13.57x the $15.9146 out-year estimate and 22.78x book, with a supplied of 0.258 — optically cheap on forward earnings relative to growth, but the forward multiple rests entirely on an out-year estimate 70.9% above the current-year $9.31242. Absolute valuation remains demanding: 17.22x sales, 25.14x and a 0.8% free-cash-flow yield against a 4.986% ten-year Treasury yield, a negative spread of roughly 419 basis points. The supplied enterprise value of $5.0605 trillion is 0.97x the $5.2158 trillion market cap, consistent with the $23.61 billion net-cash position, which is only 0.45% of market cap and therefore a stability feature rather than a valuation floor. Price sits at the 65.4 percentile of its 52-week range, 11.25% below the $243.37 high and 31.49% above the $164.27 low, while the stock is down 4.03% over the trailing month but up 1.81% year-to-date despite 105.9% revenue growth and 127.8% earnings growth. The bundle supplies no peer or historical multiple series, so a precise ranking against AMD, Broadcom or Micron is not supportable. On available evidence NVDA is attractive on forward earnings relative to growth and expensive on sales, book and free cash flow — a profile that requires continued estimate escalation to defend the price.
Balance Sheet
$62.47 billion of cash against $38.86 billion of debt leaves $23.61 billion of net cash, a 1.61x cash-to-debt ratio and 3.46x operating-cash-flow-to-debt coverage, with $41.81 billion of free cash flow generated from $134.36 billion of operating cash flow. Current and quick ratios of 4.59 and 2.92 are strong for a capital-intensive semiconductor manufacturer, and the balance sheet requires no external capital to fund the current ramp. The caveat is scale: $23.61 billion of net cash equals only 0.45% of the $5.216 trillion market cap, so the balance sheet is a resilience feature rather than a valuation floor. The reported debt-to-equity of 16.97x remains anomalous next to a net-cash position and the supplied data do not reconcile it; treat it as an accounting-structure caveat rather than evidence of leverage stress, but do not ignore it — it also likely flatters the 117.21% .
Growth
Revenue grew 105.9% year over year and earnings grew 127.8%, with reported rising sequentially across all six supplied quarters from $0.81 to $1.05, $1.30, $1.62, $1.87 and $2.22 — a trajectory consistent with continuing expansion rather than a peak. Sequential growth rates were +29.6%, +23.8%, +24.6%, +15.4% and +18.7%, so the percentage pace has cooled modestly even as absolute dollar keeps making new highs. Operating cash flow of $134.36 billion converts to $41.81 billion of free cash flow, roughly 31%, implying a $92.55 billion investment and working-capital burden the bundle does not itemize; that reinvestment is appropriate in the current demand environment but is the first place stress would appear if growth decelerates. Growth durability, not the current level, remains the single most important variable in the thesis, and the 21-day countdown to the November 17 print is when the market re-tests it.
Business Quality
The business pairs a 74.67% gross margin with a 66.24% operating margin, a 66.43% margin and a 63.66% net margin — among the strongest margin structures in large-cap technology. of 53.57% and of 117.21% are exceptional, although the figure sits alongside an unreconciled 16.97x debt-to-equity ratio and may be flattered by a compressed equity base. Liquidity ratios of 4.59 current and 2.92 quick are comfortable, and institutional ownership of 71.41% against 4.01% insider ownership describes a widely held, highly liquid mega-cap with 1.34% short interest in float and a 2.75 short ratio. Platform and developer-ecosystem lock-in underpins the premium economics, but the DeepSeek-Huawei open-source Ascend programming backbone is the clearest structural challenge to that moat in the supplied data because it targets precisely the software layer that creates switching costs.
Capital Allocation
With $23.61 billion of net cash and $134.36 billion of operating cash flow, NVIDIA funds research, product ramp and working capital internally without external capital. The dividend yield is 0.47% with a 3.54% payout ratio, so essentially all earnings are retained and reinvested rather than returned. Shares outstanding are 24.147 billion with 23.133 billion in the float, but the bundle supplies no share-count history, buyback authorization or dilution detail, so repurchase effectiveness cannot be assessed and per-share capital allocation is unverifiable this run. The roughly $92.55 billion gap between operating cash flow and free cash flow points to heavy reinvestment and working-capital build — defensible today, but the single largest swing factor if the demand curve flattens.
Estimate Revisions
Out-year expectations remain the strongest part of the story: the +1-year estimate has risen to $15.9146 from $12.81483 ninety days ago (+24.19%), with seven upward and zero downward revisions over 30 days and three upward over the last seven days. The current-year estimate is up about 4.00% over 90 days ($9.31242 versus $8.95389) with two upward and zero downward 30-day revisions. Near-term estimates have flattened and turned slightly negative: both the current quarter and the next quarter show one downward revision and zero upward revisions over the past 7 and 30 days, the current-quarter estimate slipped over 30 days ($2.47325 versus $2.47356, -0.01%), and the next-quarter estimate moved from $2.74295 to $2.74622 (+0.12%). The revision signal is therefore strongly positive on the twelve-month horizon and marginally negative into the November 17 print — a classic good-long-term-story, high-near-term-bar setup. No upgrades or downgrades were recorded in the last 90 days; recent actions were maintenance or initiation of constructive ratings (Needham Buy maintained at $300 on October 22, Cantor Fitzgerald Overweight maintained at $350 on October 1, Rosenblatt Buy maintained at $390 on September 29, Piper Sandler Overweight initiated at $300 on September 10).